Kiran Mazumdar-Shaw
Chairperson and Managing Director, Biocon
Meet Kiran Mazumdar-Shaw
Kiran says that over the past five years, her understanding of risk management has greatly deepened. “I believe that I can now invest with greater confidence in some of the exciting new areas in immuno-oncology and digital technologies that will augment the pace of research and innovation.” She considers her luckiest break discovering the “ability to transform my original enzymes business into biopharmaceuticals by leveraging the various microbial and rDNA technologies in a strategic way.”